Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Synthetic Biologics Inc (SYN)

0.5968   -0.005 (-0.9%) 04-13 09:43
Open: 0.632 Pre. Close: 0.6022
High: 0.5968 Low: 0.5818
Volume: 641,210 Market Cap: 77M
Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. The company is headquartered in Rockville, Maryland and currently employs 13 full-time employees. The firm is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The firm's lead product candidates in Phase II development are SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). Its other product candidates include SYN-007, SYN-006, SYN-005, SYN-200 and SYN-020. The firm is also developing preclinical-stage monoclonal antibody therapies for the prevention and treatment of pertussis, and discovery-stage biotherapeutics for the treatment of phenylketonuria (PKU).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.631 - 0.635 0.635 - 0.639
Low: 0.58 - 0.584 0.584 - 0.588
Close: 0.593 - 0.599 0.599 - 0.607

Technical analysis

as of: 2021-04-12 5:00:18 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.97     One year: 1.16
Support: Support1: 0.57    Support2: 0.47
Resistance: Resistance1: 0.83    Resistance2: 0.99
Pivot: 0.67
Moving Average: MA(5): 0.64     MA(20): 0.71
MA(100): 0.65     MA(250): 0.52
MACD: MACD(12,26): -0.03     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 16.54     %D(3): 19.01
RSI: RSI(14): 39.49
52-week: High: 1.70  Low: 0.25  Change(%): 77.1
Average Vol(K): 3-Month: 1551388  10-Days: 369789

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
SYN has closed above bottom band by 3.5%. Bollinger Bands are 54.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to SYN's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 08 Apr 2021
Synthetic Biologics Inc (SYN) gains 1.4% for April 08 - Equities.com

Wed, 07 Apr 2021
Synthetic Biologics Inc (SYN) falls 4.77% for April 07 - Equities.com

Mon, 05 Apr 2021
Synthetic Biologics (SYN) is Gaining Momentum Recently – Own Snap - Own Snap

Thu, 01 Apr 2021
Synthetic Biologics Announces First Six Participants Dosed in Phase 1a Clinical Trial of SYN-020 Intestinal Alkaline Phosphatase - PRNewswire

Thu, 25 Mar 2021
Synthetic Biologics - Consensus Indicates Potential 168.6% Upside - DirectorsTalk Interviews

Tue, 23 Mar 2021
Synthetic Biologics Inc. (SYN) Plunges 8.78% on March 23 - Equities.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19
Shares Float (M) 19
% Held by Insiders 0.13
% Held by Institutions 8.72
Shares Short (K) 61
Shares Short P. Month (K) 206

Stock Financials

EPS -0.877
EPS Est This Year -0.170
EPS Est Next Year -0.250
Book Value (p.s.) -0.400
Profit Margin
Operating Margin
Return on Assets (ttm) -53.5
Return on Equity (ttm) -111.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.727
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -8

Stock Valuations

PE Ratio -0.69
PEG Ratio
Price to Book value -1.51
Price to Sales
Price to Cash Flow -0.86

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.